81P Impact of FIGO 2023 staging and molecular classification on stage migration and adjuvant treatment decisions in endometrial cancer: Results from a multicentric prospective Indian cohort (MECASIS)
The 2023 FIGO staging system integrates molecular classification into endometrial cancer staging, potentially leading to stage migration and changes in treatment decisions. Real-world data from low- and middle-income countries (LMICs), where access to molecular testing is variable, remain limited.
Authors
- K.K. Rathnam
- S.L. Cyriac
- A.O. Philips
- S.S. Panda
- I. Bhavya
- S.V. Saju
- R. B
- A. Sehrawat
- D. Sundriyal
- V. S
- F. Antony
- P. Menon
- D. S
- P. Ganesan
- N. Devi R
- A.K. M
- A. Rg
- S. Dash
- B. Thomas
- D. Thampan
Institutions
- Malabar Cancer Centre (IN)
- Amala Institute of Medical Sciences (IN)
- Meenakshi Mission Hospital and Research Centre (IN)
- Institute of Medical Sciences and Sum Hospital (IN)
- All India Institute of Medical Sciences Rishikesh (IN)
- Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-07-01
- DOI
- https://doi.org/10.1016/j.esmoop.2026.108108
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00